調查批次:CHT2015-10 | 檢體寄出日期:2015-10-26 | 報告回收截止日期:2015-11-02 | 回收份數:21 |
FT4 檢驗院際品管調查結果: | ||
2.歷次品管檢體 FT4 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
2 |
5 |
1.40 |
-0.21 |
-13.0 |
-1.6 |
-0.9 |
-54 |
2.90 |
-0.63 |
-17.8 |
-2.3 |
-0.7 |
-75 |
RH07b | RH07 | 7 |
2 |
3 |
1.73 |
0.12 |
7.5 |
0.9 |
1.1 |
31 |
3.94 |
0.41 |
11.6 |
1.5 |
0.6 |
49 |
RH14 | RH14 | 4 |
2 |
3 |
1.63 |
0.02 |
1.2 |
0.2 |
0.5 |
5 |
4.08 |
0.55 |
15.6 |
2.0 |
0.7 |
65 |
RH15 | RH15 | 7 |
2 |
5 |
1.54 |
-0.07 |
-4.3 |
-0.5 |
-0.1 |
-18 |
2.73 |
-0.80 |
-22.7 |
-2.9 |
-0.8 |
-95 |
CL009 | CL009 | 4 |
2 |
5 |
1.35 |
-0.26 |
-16.1 |
-2.0 |
-1.2 |
-67 |
2.58 |
-0.95 |
-26.9 |
-3.4 |
-1.0 |
-113 |
CL010 | CL010 | 3 |
2 |
5 |
1.42 |
-0.19 |
-11.8 |
-1.5 |
-0.8 |
-49 |
2.58 |
-0.95 |
-26.9 |
-3.4 |
-1.0 |
-113 |
CL012 | CL012 | 7 |
2 |
3 |
1.51 |
-0.10 |
-6.2 |
-0.8 |
-0.2 |
-26 |
4.33 |
0.80 |
22.7 |
2.9 |
1.0 |
95 |
CL013 | CL013 | 3 |
2 |
5 |
1.54 |
-0.07 |
-4.3 |
-0.5 |
-0.1 |
-18 |
3.66 |
0.13 |
3.7 |
0.5 |
0.2 |
15 |
CL015 | CL015 | 4 |
2 |
3 |
1.85 |
0.24 |
14.9 |
1.8 |
1.8 |
62 |
4.38 |
0.85 |
24.1 |
3.0 |
1.1 |
101 |
Median of RIA Group |
1.54 |
3.66 |
||||||||||||||
Range of RIA Group |
1.35 - 1.85 |
2.58 - 4.38 |
||||||||||||||
Robust mean of RIA Group |
1.55 ( n = 9 ) |
3.46 ( n = 9 ) |
||||||||||||||
Robust SD of RIA Group |
0.17 |
0.86 |
||||||||||||||
CV of RIA Group |
11.0% |
24.9% |
||||||||||||||
Median of European RIA Labs |
1.53 ( n = 101 ) |
3.08 ( n = 101 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
1.41 - 1.72 |
2.74 - 3.55 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
( ng/dL ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 3 |
4 |
9 |
1.78 |
0.17 |
10.6 |
1.3 |
1.2 |
44 |
3.90 |
0.37 |
10.5 |
1.3 |
1.3 |
44 |
RH02c | RH02 | 1 |
4 |
1 |
1.26 |
-0.35 |
-21.7 |
-2.7 |
-0.8 |
-90 |
2.71 |
-0.82 |
-23.2 |
-2.9 |
-1.0 |
-98 |
RH06 | RH06 | 2 |
4 |
9 |
1.79 |
0.18 |
11.2 |
1.4 |
1.3 |
46 |
3.67 |
0.14 |
4.0 |
0.5 |
0.9 |
17 |
RH07a | RH07 | 1 |
4 |
2 |
1.37 |
-0.24 |
-14.9 |
-1.8 |
-0.3 |
-62 |
3.05 |
-0.48 |
-13.6 |
-1.7 |
-0.3 |
-57 |
RH12 | RH12 | 7 |
4 |
2 |
1.32 |
-0.29 |
-18.0 |
-2.2 |
-0.5 |
-74 |
3.14 |
-0.39 |
-11.0 |
-1.4 |
-0.2 |
-46 |
RH19 | RH19 | 2 |
4 |
2 |
1.17 |
-0.44 |
-27.3 |
-3.4 |
-1.1 |
-113 |
3.05 |
-0.48 |
-13.6 |
-1.7 |
-0.3 |
-57 |
RH20 | RH20 | 3 |
4 |
7 |
1.42 |
-0.19 |
-11.8 |
-1.5 |
-0.2 |
-49 |
2.86 |
-0.67 |
-19.0 |
-2.4 |
-0.7 |
-80 |
CL005 | CL005 | 7 |
4 |
9 |
1.76 |
0.15 |
9.3 |
1.2 |
1.2 |
38 |
3.67 |
0.14 |
4.0 |
0.5 |
0.9 |
17 |
CL006a | CL006 | 3 |
4 |
7 |
1.38 |
-0.23 |
-14.3 |
-1.8 |
-0.3 |
-59 |
2.91 |
-0.62 |
-17.6 |
-2.2 |
-0.6 |
-74 |
CL008 | CL008 | 4 |
4 |
2 |
1.43 |
-0.18 |
-11.2 |
-1.4 |
-0.1 |
-46 |
3.46 |
-0.07 |
-2.0 |
-0.3 |
0.5 |
-8 |
CL011 | CL011 | 1 |
4 |
13 |
1.64 |
0.03 |
1.9 |
0.2 |
0.7 |
8 |
3.73 |
0.20 |
5.7 |
0.7 |
1.0 |
24 |
CL014b | CL014 | 4 |
4 |
1 |
1.21 |
-0.40 |
-24.8 |
-3.1 |
-1.0 |
-103 |
2.50 |
-1.03 |
-29.2 |
-3.7 |
-1.4 |
-123 |
Median of CLIA Group |
1.40 |
3.10 |
||||||||||||||
Range of CLIA Group |
1.17 - 1.79 |
2.50 - 3.90 |
||||||||||||||
Robust mean of CLIA Group |
1.46 ( n = 12 ) |
3.22 ( n = 12 ) |
||||||||||||||
Robust SD of CLIA Group |
0.26 |
0.51 |
||||||||||||||
CV of CLIA Group |
17.8% |
15.8% |
||||||||||||||
Median of European CLIA Labs |
1.62 ( n = 1030 ) |
3.60 ( n = 1030 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
1.27 - 1.73 |
2.77 - 3.89 |
||||||||||||||
Median of All Labs |
1.43 |
3.14 |
||||||||||||||
Range of All Labs |
1.17 - 1.85 |
2.50 - 4.38 |
||||||||||||||
Robust mean of All Labs |
1.50 ( n = 21 ) |
3.32 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
0.23 |
0.68 |
||||||||||||||
CV of All Labs |
15.3% |
20.5%
|
||||||||||||||
Median of All European Labs ( Xa ) |
1.61 |
3.53 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
1.28 - 1.73 |
2.76 - 3.89 |
||||||||||||||
Mean of All European Labs |
1.54 ( n = 1196 ) |
3.38 ( n = 1196 ) |
||||||||||||||
SD of All European Labs |
0.212 |
0.546 |
||||||||||||||
CV of All European Labs |
13.8% |
16.1% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.129 |
0.282 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Competitive-type ) |
2 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL015, |
Chemiluminescent Immunoassay ( Competitive-type ) |
4 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, CL014b, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, CL014b, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH07b, RH14, CL012, CL015, |
Immunotech |
5 |
RH01b, RH15, CL009, CL010, CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2015-11-03